ACH
NVRO

ArrowMark Colorado Holdings’s NEVRO CORP. NVRO Stock Holding History

ArrowMark Colorado Holdings’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,361,282
Closed -$16.2M – 325
2024
Q4 		$16.2M Sell
4,361,282
-29,976
-0.7% -$138K 0.22% 104
2024
Q3 		$24.5M Buy
4,391,258
+102,150
+2% +$715K 0.31% 84
2024
Q2 		$36.1M Buy
4,289,108
+1,493,205
+53% +$15.9M 0.43% 67
2024
Q1 		$40.4M Sell
2,795,903
-215,156
-7% -$3.56M 0.45% 62
2023
Q4 		$64.8M Buy
3,011,059
+542,949
+22% +$9.69M 0.72% 44
2023
Q3 		$47.4M Buy
2,468,110
+650,921
+36% +$13.9M 0.58% 58
2023
Q2 		$46.2M Buy
1,817,189
+485,433
+36% +$14M 0.51% 62
2023
Q1 		$48.1M Buy
1,331,756
+79,538
+6% +$2.79M 0.55% 56
2022
Q4 		$49.6M Buy
1,252,218
+101,158
+9% +$4.21M 0.59% 53
2022
Q3 		$53.6M Sell
1,151,060
-10,953
-0.9% -$508K 0.66% 51
2022
Q2 		$50.9M Buy
1,162,013
+306,574
+36% +$16.9M 0.58% 56
2022
Q1 		$61.9M Buy
855,439
+113,107
+15% +$8.15M 0.54% 57
2021
Q4 		$60.2M Buy
742,332
+307,973
+71% +$30.9M 0.48% 65
2021
Q3 		$50.6M Buy
434,359
+54,302
+14% +$7.11M 0.4% 73
2021
Q2 		$63M Buy
380,057
+90,347
+31% +$14.1M 0.47% 64
2021
Q1 		$40.4M Sell
289,710
-13,184
-4% -$2.15M 0.3% 87
2020
Q4 		$52.4M Sell
302,894
-38,107
-11% -$6.17M 0.41% 74
2020
Q3 		$47.5M Sell
341,001
-84,122
-20% -$11.2M 0.45% 65
2020
Q2 		$50.8M Sell
425,123
-35,772
-8% -$4.24M 0.52% 62
2020
Q1 		$46.1M Sell
460,895
-113,131
-20% -$13.6M 0.61% 57
2019
Q4 		$67.5M Sell
574,026
-27,477
-5% -$2.72M 0.6% 59
2019
Q3 		$51.7M Sell
601,503
-325,253
-35% -$24.6M 0.52% 66
2019
Q2 		$60.1M Sell
926,756
-955,253
-51% -$59.5M 0.58% 64
2019
Q1 		$118M Buy
1,882,009
+95,486
+5% +$4.49M 1.11% 28
2018
Q4 		$69.5M Buy
1,786,523
+542,183
+44% +$24.1M 0.73% 49
2018
Q3 		$70.9M Buy
1,244,340
+298,348
+32% +$18.6M 0.59% 56
2018
Q2 		$75.5M Buy
945,992
+183,193
+24% +$15.2M 0.69% 49
2018
Q1 		$66.1M Sell
762,799
-130
-0% -$10.5K 0.66% 55
2017
Q4 		$52.7M Sell
762,929
-983
-0.1% -$78.6K 0.53% 68
2017
Q3 		$69.4M Buy
763,912
+37,363
+5% +$3.2M 0.79% 40
2017
Q2 		$54.1M Buy
726,549
+385,286
+113% +$30.9M 0.67% 53
2017
Q1 		$32M Sell
341,263
-93,039
-21% -$8.43M 0.44% 82
2016
Q4 		$31.6M Buy
434,302
+186,481
+75% +$16M 0.5% 67
2016
Q3 		$25.9M Sell
247,821
-52,144
-17% -$4.71M 0.47% 77
2016
Q2 		$22.1M Sell
299,965
-101,704
-25% -$6.9M 0.45% 79
2016
Q1 		$22.6M Buy
+401,669
New +$23.7M 0.5% 72
2015
Q4 		– Sell
-56,687
Closed -$2.63M – 282
2015
Q3 		$2.63M Buy
56,687
+8,548
+18% +$414K 0.07% 177
2015
Q2 		$2.59M Buy
48,139
+18,806
+64% +$958K 0.06% 195
2015
Q1 		$1.41M Buy
29,333
+3,805
+15% +$165K 0.04% 215
2014
Q4 		$987K Buy
+25,528
New +$804K 0.03% 217

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ArrowMark Colorado Holdings's NVRO Position: Q1 2025 in Review

ArrowMark Colorado Holdings sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 4,361,282 shares — an estimated $16.2M sold.

ArrowMark Colorado Holdings first reported a position in NVRO in Q4 2014 and held it in 40 quarters. The position peaked at $118M in Q1 2019. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • ArrowMark Colorado Holdings reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 4,361,282 NEVRO CORP. shares in Q1 2025, an estimated $16.2M.
  • ArrowMark Colorado Holdings first reported a position in NEVRO CORP. in Q4 2014 and held it in 40 quarters.
  • ArrowMark Colorado Holdings's NEVRO CORP. position peaked at $118M in Q1 2019.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2025, filed 15 May 2025.